Azilsartan Medoxomil: A New Angiotensin Receptor Blocker von Zaiken, Kathy, PharmD, Cheng, Judy W.M., PharmD, MPH, FCCP, BCPS

Volltext

Dabigatran Etexilate: An Oral Direct Thrombin Inhibitor for the Management of Thromboembolic Disorders von Cheng, Judy W.M., BS, PharmD, MPH, FCCP, BCPS, Vu, Huyen

Volltext

Aliskiren: Renin inhibitor for hypertension management von Cheng, Judy W.M., BS, PharmD, MPH, FCCP, BCPS

Volltext

Ticagrelor: Oral Reversible P2Y12 Receptor Antagonist for the Management of Acute Coronary Syndromes von Cheng, Judy W.M., PharmD, MPH, FCCP, BCPS

Volltext

Ambrisentan for the management of pulmonary arterial hypertension von Cheng, Judy W.M., BS, PharmD, MPH, FCCP, BCPS

Volltext

Pharmacology and therapeutics of ezetimibe (SCH 58235), a cholesterol-absorption inhibitor von Jeu, LilyAnn, Cheng, Judy W.M.

Volltext

New and emerging antiarrhythmic and anticoagulant agents for atrial fibrillation von Cheng, Judy W M

Volltext

Nebivolol: A third-generation β-blocker for hypertension von Cheng, Judy W.M., BS, PharmD, MPH, FCCP, BCPS

Volltext

Comparison of Ambulatory, High-Dose, Intravenous Diuretic Therapy to Standard Hospitalization and Diuretic Therapy for Treatment of Acute Decompensated Heart Failure von Buckley, Leo F., PharmD, Seoane-Vazquez, Enrique, PhD, Cheng, Judy W.M., PharmD MPH, Aldemerdash, Ahmed, PharmD, Cooper, Irene M., RN, Matta, Lina, PharmD MPH, Medina, Danika S., RN, Mehra, Mandeep R., MD, Navarro-Velez, Kristina, RN, Shea, Elaine L., RN, Weintraub, Joanne R., NP, Stevenson, Lynne W., MD, Desai, Akshay S., MD MPH

Volltext

Updates on Cytochrome P450-Mediated Cardiovascular Drug Interactions von Cheng, Judy W.M., PharmD, MPH, FCCP, BCPS, Frishman, William H., MD, Aronow, Wilbert S., MD

Volltext

Prevention and Treatment of Venous Thromboembolic Events: Focus on Dabigatran Etexilate von Cheng, Judy W.M.

Volltext

Rosuvastatin in the management of hyperlipidemia von Cheng, Judy W.M.

Volltext

A Cardiovascular Pharmacotherapy Elective Course to Enhance Pharmacy Students’ Literature Evaluation Skills and Ability to Apply Clinical Evidence von Cheng, Judy W.M.

Volltext

Antiplatelet Therapy After Placement of a Drug-Eluting Stent: A Review of Efficacy and Safety Studies von Mohammad, Rima A., PharmD, BCPS, Goldberg, Tamara, PharmD, BCPS, Dorsch, Michael P., PharmD, MS, BCPS, Cheng, Judy W.M., PharmD, MPH, BCPS, FCCP

Volltext

Financial Implications of Ambulatory Diuretic Therapy Instead of Hospitalization for the Treatment of Decompensated Heart Failure von Buckley, Leo F, Seoane-Vazquez, Enrique, Cheng, Judy W.M, Aldemerdash, Ahmed, Cooper, Irene M, Matta, Lina, Medina, Danika S, Mehra, Mandeep R, Navarro-Velez, Kristina, Shea, Elaine L, Weintraub, Joanne R, Stevenson, Lynne W, Desai, Akshay S

Volltext

A review of isosorbide dinitrate and hydralazine in the management of heart failure in black patients, with a focus on a new fixed-dose combination von Cheng, Judy W.M.

Volltext

Ranolazine for the management of coronary artery disease von Cheng, Judy W.M.

Volltext

Sodium-Glucose Cotransporter 2 Inhibitors Among Heart Failure With Mildly Reduced and Preserved Ejection Fraction von Cheng, Judy W. M., Colucci, Vincent, Kalus, James S., Spinler, Sarah A.

Volltext

Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin-Converting Enzyme 2 von Buckley, Leo F., Cheng, Judy W. M., Desai, Akshay

Volltext

Focused Updates: SGLT2 Inhibitors in Patients With Heart Failure and/or Chronic Kidney Disease von Cheng, Judy W. M., Colucci, Vincent, Kalus, James S., Spinler, Sarah A.

Volltext